Johnson & Johnson : JNJ

All Johnson & Johnson Articles

1192 Articles

Jon C. Ogg | Oct 9, 2017 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: Ctrip, Goldman Sachs, Johnson & Johnson, Medtronic, Morgan Stanley, Yelp, Yum China and More

The top analyst upgrades, downgrades and other research calls from Monday include Ctrip.com, Goldman Sachs, Johnson & Johnson, Medtronic, Morgan…

Jon C. Ogg | Oct 3, 2017 at 10:55 AM EDT

Credit Suisse Identifies Top Mid-Large Cap Biotech and Pharma Stocks for Big Upside

U.S. pharmaceutical and biotech stocks may have considerable upside if Credit Suisse's views come to pass. But this part of…

Chris Lange | Sep 30, 2017 at 8:20 AM EDT

Major Biotech, Pharma and FDA Catalysts Coming in October

24/7 Wall St. has collected several catalysts that are coming up in October for biotech and pharmaceutical companies.

Jon C. Ogg | Sep 25, 2017 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: Albermarle, Blue Apron, Box, Dish Network, GM, Transocean, Under Armour and More

The top analyst upgrades, downgrades and other research calls from Monday include Albermarle, Blue Apron, Box, Dish Network, GM, Transocean…

Paul Ausick | Sep 21, 2017 at 4:01 PM EDT

Apple, Procter & Gamble Sink the DJIA Thursday

Apple, P&G, Johnson & Johnson, and Verizon led the DJIA lower on Thursday.

Jon C. Ogg | Sep 20, 2017 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: Biogen, Electronic Arts, Gap, Intuit, J&J, 3M, Intercept, AutoZone and More

The top analyst upgrades, downgrades and other research calls from Wednesday include Biogen, Electronic Arts, Gap, Intuit, Johnson & Johnson,…

Chris Lange | Sep 14, 2017 at 1:35 PM EDT

Why Pfizer Is Pushing the Dow to All-Time Highs

Although the markets were mixed on Thursday, major drug manufacturers proved to be one of the more positive segments on…

Jon C. Ogg | Sep 13, 2017 at 7:15 AM EDT

Merrill Lynch Top Health Care Stock Picks for September: Focus on Large Cap Biotech

According to Merrill Lynch, the health care sector should act as a good hedge against volatility. Even biotech was shown…

Chris Lange | Sep 11, 2017 at 8:50 AM EDT

Achillion Pharma Slides After Hep C Deal Is Terminated

Achillion Pharmaceuticals saw its shares slump early on Monday after the firm announced that its hepatitis C license and collaboration…

Paul Ausick | Aug 23, 2017 at 4:01 PM EDT

Johnson & Johnson, Disney Lead DJIA Lower Wednesday

Johnson & Johnson, Cisco Systems, Disney, and Caterpillar led the DJIA downward on Wednesday.

Paul Ausick | Aug 21, 2017 at 9:04 AM EDT

10 Companies with the Biggest 2016 Share Buybacks

Companies included on the S&P 500 index bought back more than $500 billion in stock last year and have bought…

Paul Ausick | Aug 15, 2017 at 9:00 AM EDT

Amazon: The Devil You Know and the Devil You Don’t

One thing investors wanted to hear on conference calls this earnings season was how companies are responding to Amazon. One…

Paul Ausick | Aug 8, 2017 at 4:01 PM EDT

Merck, DuPont Lead Dow Lower on Tuesday

Merck, Johnson & Johnson, DuPont, and Verizon led the 20 stocks that were heading for a lower close just minutes…

Jon C. Ogg | Aug 2, 2017 at 1:20 PM EDT

Blockbuster Drug Imbruvica Gets Expanded FDA Approval for Chronic Graft Versus Host Disease

A blockbuster drug is about to get a chance to have even higher sales, as the FDA has expanded its…

Paul Ausick | Jul 24, 2017 at 4:01 PM EDT

GE, Nike Guide DJIA Down on Monday

General Electric, Nike, Home Depot, and Johnson & Johnson led the DJIA lower Monday.

1 … 34 35 36 37 38 … 80

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

Top Analyst Upgrades and Downgrades: Ctrip, Goldman Sachs, Johnson & Johnson, Medtronic, Morgan Stanley, Yelp, Yum China and More

Credit Suisse Identifies Top Mid-Large Cap Biotech and Pharma Stocks for Big Upside

Major Biotech, Pharma and FDA Catalysts Coming in October

Top Analyst Upgrades and Downgrades: Albermarle, Blue Apron, Box, Dish Network, GM, Transocean, Under Armour and More

Apple, Procter & Gamble Sink the DJIA Thursday

Top Analyst Upgrades and Downgrades: Biogen, Electronic Arts, Gap, Intuit, J&J, 3M, Intercept, AutoZone and More

Why Pfizer Is Pushing the Dow to All-Time Highs

Merrill Lynch Top Health Care Stock Picks for September: Focus on Large Cap Biotech

Achillion Pharma Slides After Hep C Deal Is Terminated

Johnson & Johnson, Disney Lead DJIA Lower Wednesday

10 Companies with the Biggest 2016 Share Buybacks

Amazon: The Devil You Know and the Devil You Don’t

Merck, DuPont Lead Dow Lower on Tuesday

Blockbuster Drug Imbruvica Gets Expanded FDA Approval for Chronic Graft Versus Host Disease

GE, Nike Guide DJIA Down on Monday

Famous Wall Street Tech Analyst Names Meta and Amazon the Best Magnificent 7 Stock Buys Today

Prediction: Alphabet Stock Will Outpace the Market in 2026

XRP, Bitcoin, and Ethereum Slip as Lebanon Strikes Threaten to Unravel the Iran Ceasefire

The RFK Jr. Medicare AI Program Already Denying Seniors Care in 6 States

They Dream of Retiring On The Road. How Big a Portfolio Do They Need for RV Living?

3 Stocks to Buy Now Before Wall Street Catches On

Famous Wall Street Tech Analyst Names Meta and Amazon the Best Magnificent 7 Stock Buys Today

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

Top Analyst Upgrades and Downgrades: Ctrip, Goldman Sachs, Johnson & Johnson, Medtronic, Morgan Stanley, Yelp, Yum China and More

Credit Suisse Identifies Top Mid-Large Cap Biotech and Pharma Stocks for Big Upside

Major Biotech, Pharma and FDA Catalysts Coming in October

Top Analyst Upgrades and Downgrades: Albermarle, Blue Apron, Box, Dish Network, GM, Transocean, Under Armour and More

Apple, Procter & Gamble Sink the DJIA Thursday

Top Analyst Upgrades and Downgrades: Biogen, Electronic Arts, Gap, Intuit, J&J, 3M, Intercept, AutoZone and More

Why Pfizer Is Pushing the Dow to All-Time Highs

Merrill Lynch Top Health Care Stock Picks for September: Focus on Large Cap Biotech

Achillion Pharma Slides After Hep C Deal Is Terminated

Johnson & Johnson, Disney Lead DJIA Lower Wednesday

10 Companies with the Biggest 2016 Share Buybacks

Amazon: The Devil You Know and the Devil You Don’t

Merck, DuPont Lead Dow Lower on Tuesday

Blockbuster Drug Imbruvica Gets Expanded FDA Approval for Chronic Graft Versus Host Disease

GE, Nike Guide DJIA Down on Monday

Famous Wall Street Tech Analyst Names Meta and Amazon the Best Magnificent 7 Stock Buys Today

Prediction: Alphabet Stock Will Outpace the Market in 2026

XRP, Bitcoin, and Ethereum Slip as Lebanon Strikes Threaten to Unravel the Iran Ceasefire

Featured Reads

The RFK Jr. Medicare AI Program Already Denying Seniors Care in 6 States

They Dream of Retiring On The Road. How Big a Portfolio Do They Need for RV Living?